Cargando…
A Multimodality Approach to Assessing Factor I Genetic Variants in Atypical Hemolytic Uremic Syndrome
Autores principales: | Java, Anuja, Pozzi, Nicola, Love-Gregory, Latisha D., Heusel, Jonathan W., Sung, Yun Ju, Hu, Zheng, Bertram, Paula, Liszewski, M. Kathryn, Cline, Laura M., Ren, Zhen, Atkinson, John P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609824/ https://www.ncbi.nlm.nih.gov/pubmed/31312772 http://dx.doi.org/10.1016/j.ekir.2019.04.003 |
Ejemplares similares
-
Clinicopathologic Implications of Complement Genetic Variants in Kidney Transplantation
por: Ren, Zhen, et al.
Publicado: (2021) -
Treatment preference and quality of life impact: ravulizumab vs eculizumab for atypical hemolytic uremic syndrome
por: Mauch, Teri J, et al.
Publicado: (2023) -
Atypical hemolytic uremic syndrome
por: Loirat, Chantal, et al.
Publicado: (2011) -
Atypical Hemolytic Uremic Syndrome
por: Kavanagh, David, et al.
Publicado: (2013) -
Hyperfunctional complement C3 promotes C5-dependent atypical hemolytic uremic syndrome in mice
por: Smith-Jackson, Kate, et al.
Publicado: (2019)